Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05637606Completed
Randomised, single-blind trial (2 arms), sponsored by Humanitas Research Hospital. Primary endpoint: Composite of 30-day mortality and major organ dysfunction. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05637606.